IDEX's performance is satisfactory, particularly its substantial investment in its business and high rate of return, which has resulted in significant earnings growth. Analysts expect the company to continue its recent growth streak.
IDEX's high P/E ratio is worrisome due to its poor earnings forecast. Despite investor hopes for a business turnaround, analysts remain skeptical. The high P/E ratio may not be justified by future earnings unless conditions drastically improve.
James Ward of Artemis sees a bright future for STC under IDEX. STC's CEO, James Callan, lauds Artemis for their market understanding that fostered STC's growth.
IDEX's regular capital reinvestment at decent returns may be spurring its stock's five-year growth. This expected trend can make the stock appealing for investors.
IDEX's statutory earnings could be misleading due to the unusual items affecting profits. The true underlying earnings power of IDEX may be less than its statutory profit, unique factors providing temporary boosts to its profits.
IDEX's rapid earnings growth and conservatively low payout ratio signals significant business reinvestment, making it a potentially appealing dividend stock.
アイデックスに関するコメント
• $ボルグワーナー (BWA.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $48 (from $43)
• $エクスペンシファイ・インク (EXFY.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $25 (from $20)
• $グラブ・ホールディングス (GRAB.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $3
• $フーリハン・ローキー (HLI.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $82 (from $95)
• $ジェイピー・モルガン・チェース (JPM.US)$ : Berenberg Upgrades to Hold from Sell - PT ...
まだコメントはありません